Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 43 recruiting now full pipeline

Substance Use Disorders: full-pipeline trial registry

43 of 94 indexed Substance Use Disorders trials are currently recruiting.

Corpus placement: #143 of 28,707 conditions by registered trial count.

94 US clinical trials · 43 currently recruiting · #143 of 28,707 conditions by registered trial count

Substance Use Disorders: 94 US clinical trials tracked, 43 recruiting.

Substance Use Disorders is the subject of 94 registered US clinical trials on ClinicalTrials.gov, 43 of them currently open to new participants. 5 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is VA Office of Research and Development, running 6 of these trials.

Enrollment posture brief

Registry condition substance-use-disorders

OPEN 43 | RECR 46% | LATE 5 | EARLY 5 | RANK #143 | SPON 6

Nearest open-share peer: Waldenstrom Macroglobulinemia (46% recruiting · 35 trials)

Metastatic Malignant Solid N49.5%Substance Use Disorders (thi…46%Suicide44.1%Glaucoma41.5%Fallopian Tube Cancer29%
Open-enrollment share among volume-matched conditions near Substance Use Disorders

Substance Use Disorders lists 43 open slots (46% of 94 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Substance Use Disorders on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Substance Use Disorders is recruiting above its size-band peers.

    43 of 94 indexed trials (45.7%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Substance Use Disorders trials is spread across many organizations.

    VA Office of Research and Development accounts for 6 of 94 trials (6.4%). 62 distinct sponsors appear on at least one study for this condition label.

  3. Typical Substance Use Disorders enrolment sits around 120 participants.

    Median target enrolment is 120 among the 94 trials that report a genuine target (sentinel values excluded). 42 of those (44.7%) plan for fewer than 100 participants.

  4. Substance Use Disorders research is mostly interventional.

    90 interventional and 4 observational studies make up this index (95.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 23Phase 32Phase 43

Open and recent trials

94 total, page 2 of 2

ACTIVE NOT RECRUITING NA 87 participants

Mortality Reductions Based on AUD/Heavy Alcohol Use, HIV Risk, and Cardiovascular Risk

NYU Langone Health

NCT05828849

ACTIVE NOT RECRUITING NA 50 participants

Examining Feasibility and Acceptability of Telemedicine for Substance Use Disorder (SUD)

University of Michigan

NCT04768920

ACTIVE NOT RECRUITING NA 30 participants

The Human Stress Response in a Simulated ED Setting

University of Arkansas

NCT04317482

ACTIVE NOT RECRUITING NA 25 participants

Developing a Telehealth Model to Improve Treatment Access for Rural Veterans With Substance Use Disorders

VA Office of Research and Development

NCT05348317

ACTIVE NOT RECRUITING NA 24 participants

EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy

Gavin Bart

NCT04921787

ACTIVE NOT RECRUITING Phase 1 12 participants

Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder

University of Wisconsin, Madison

NCT05322954

ACTIVE NOT RECRUITING NA 11 participants

Enhancing Substance Use Treatment Services to Decrease Dropout and Improve Outpatient Treatment Utilization in Emerging Adults

UConn Health

NCT05374395

ACTIVE NOT RECRUITING NA 9 participants

Parenting Intervention for Mothers With Substance Use Disorder

Boston Medical Center

NCT06489522

COMPLETED NA 10,821 participants

Computerized Substance Use and Depression Screening and Behavioral Treatment in HIV Primary Care

University of California, San Francisco

NCT03217058

COMPLETED NA 7,950 participants

Coaching Performance Driven Practice Change in the Context of Value Based Purchasing Under New York Medicaid

NYU Langone Health

NCT04632238

COMPLETED 2,831 participants

Improving Adolescent Health Outcomes Through Preventive Care Transformation

Indiana University

NCT02244138

COMPLETED Phase 3 403 participants

Homeless Care Management App

University of Oklahoma

NCT03399500

COMPLETED NA 345 participants

Substance Abuse Self-Help Group Referral: Outcomes and Services Use

US Department of Veterans Affairs

NCT00105729

COMPLETED NA 332 participants

The Effect of a Contingency Management Intervention on Substance Use

VA Office of Research and Development

NCT00252512

COMPLETED NA 291 participants

Effectiveness of Peer-Delivered Trauma-Specific Treatment

University of New Mexi

NCT02081417

COMPLETED NA 249 participants

Project POINT: Effectiveness and Scalability of an Overdose Survivor Intervention

Indiana University

NCT03336268

COMPLETED Phase 2 209 participants

RAE (Realize, Analyze, Engage)

ContinueYou

NCT05227339

COMPLETED NA 208 participants

ART-CHESS: A Mobile Health Application to Support People Living With HIV and Addiction

University of Wisconsin, Madison

NCT03873129

COMPLETED NA 180 participants

Sequenced vs. Integrated Delivery of Treatment for Adolescent Depression and SUD

Oregon Research Institute

NCT00680966

COMPLETED NA 129 participants

Cognitive Behavioral Therapy (CBT) for PTSD in Veterans With Co-Occurring SUDs

VA Office of Research and Development

NCT01357577

COMPLETED NA 121 participants

Prevention of Substance Use in Youth in Ukraine

University of Michigan

NCT02347644

COMPLETED Phase 3 120 participants

Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)

University Hospitals Cleveland Medical Center

NCT00671853

COMPLETED 108 participants

Contingency Management Using Smartphone App in Patients With SUD

BrightView

NCT04162132

COMPLETED Early Phase 1 104 participants

Enhancing Prospective Thinking in Early Recovery (PARK)

Indiana University

NCT05908097

COMPLETED NA 103 participants

Inpatient Link to Addiction Recovery

Prisma Health-Upstate

NCT04098601

COMPLETED NA 99 participants

Barriers to Substance Use Disorder Recovery

Prisma Health-Upstate

NCT04098614

COMPLETED NA 96 participants

HCV Group Evaluation and Treatment Uptake (HCV GET-UP) Intervention

Montefiore Medical Center

NCT03242655

COMPLETED NA 80 participants

Linkage to Care for Persons with Hep C Infection

Carilion Clinic

NCT05397067

COMPLETED NA 73 participants

Improving Sleep to Reduce Risk for Substance Use Disorder

Florida State University

NCT03226132

COMPLETED NA 61 participants

Evaluating The Efficacy Of A Mind-Body Intervention In Overcoming Opioid Addiction

Ohio State University

NCT03791645

COMPLETED NA 60 participants

Individual vs. Group Community Reinforcement Training to Help Parents of Substance-using Treatment-refusing Youth

Oregon Research Institute

NCT01829789

COMPLETED NA 56 participants

Evaluating Supplementing Residential Substance Use Treatment With Written Exposure Therapy for Veterans With Post Traumatic Stress Disorder (PTSD) and Substance Use Disorders (SUD)

VA Office of Research and Development

NCT05536908

COMPLETED NA 51 participants

Planning a Multi-Level Intervention to Reduce Substance Use Stigma in HIV Prevention and Care

Wayne State University

NCT05925374

COMPLETED NA 50 participants

Written Exposure in Substance Treatment

Potomac Health Foundations

NCT06296940

COMPLETED Phase 4 50 participants

Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder

University of Massachusetts, Worcester

NCT03526354

COMPLETED NA 31 participants

HIV+ Substance Users Released From Jail

University of Texas Southwestern Medical Center

NCT03834779

COMPLETED NA 30 participants

Home-based Continuing Care for Young Adults Leaving Residential Substance Abuse Treatment

Treatment Research Institute

NCT02152033

COMPLETED NA 30 participants

Addiction Treatment Outcome Monitoring Study

University of Washington

NCT04155385

COMPLETED NA 29 participants

Families With Substance Use and Psychosis: A Pilot Study

Mclean Hospital

NCT04284813

COMPLETED NA 24 participants

AWAITS: A Web-based E-health Application for Active Illicit Opioid Users

University of Cincinnati

NCT03402672

COMPLETED Phase 4 24 participants

Treatment With Quetiapine for Youth With Substance Use Disorders and Severe Mood Dysregulation

Boston Medical Center

NCT02845453

COMPLETED NA 21 participants

Treating Violence-related PTSD and Substance Risk in Low-income, Urban Adolescents

State University of New York at Buffalo

NCT03737383

COMPLETED NA 18 participants

Parenting Young Children in Pediatrics

University of Oregon

NCT06273228

COMPLETED NA 8 participants

Open Trial to Improve Retention in Care for Persons With HIV Who Use Substances

Brown University

NCT05101044

← Previous Page 2 of 2

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 3
Phase 3 2
Phase 4 3

Named interventions

Most-linked intervention names on Substance Use Disorders records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Treatment as Usual Behavioral
3 trials
Recovery Coach Intervention Behavioral
2 trials
Written Exposure Therapy Behavioral
2 trials
Placebo Other
2 trials
Individual Community Reinforcement Training for Parents Behavioral
1 trials
Group Community Reinforcement Training for Parents Behavioral
1 trials
DOORS-CHW Intervention Behavioral
1 trials
Smartphone app Device
1 trials

US sites by state

Facility locations filed on Substance Use Disorders trials. A trial with sites in several states counts in each.

New York 13 trials
Massachusetts 11 trials
South Carolina 9 trials
Maryland 7 trials
Florida 7 trials
Oregon 6 trials
Ohio 6 trials
Michigan 6 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Substance Use Disorders page

94 registered trials, 43 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Substance Use Disorders condition card totals 94 registered trials; most-linked intervention Treatment as Usual; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.